- Investing Ideas
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
38
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
38 companies
Diaceutics
Market Cap: UK£122.7m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.45
7D
-3.3%
1Y
5.1%
Tempus AI
Market Cap: US$9.9b
Operates as a healthcare technology company in the United States.
TEM
US$54.29
7D
17.7%
1Y
-24.2%
AstraZeneca
Market Cap: UK£181.6b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£117.08
7D
-1.2%
1Y
1.1%
Vitrolife
Market Cap: SEK 12.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 91.85
7D
3.4%
1Y
-31.5%
Natera
Market Cap: US$45.5b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$310.78
7D
17.1%
1Y
96.2%
Mesoblast
Market Cap: AU$3.1b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.21
7D
-0.9%
1Y
-12.0%
Xeris Biopharma Holdings
Market Cap: US$1.5b
A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.
XERS
US$8.33
7D
13.2%
1Y
14.1%
Tecan Group
Market Cap: CHF 2.4b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 195.00
7D
1.7%
1Y
17.2%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €202.3m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€8.60
7D
3.9%
1Y
-1.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.15
7D
-0.8%
1Y
3.7%
Akeso
Market Cap: HK$95.4b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$96.00
7D
-4.0%
1Y
-42.0%
CSPC Innovation Pharmaceutical
Market Cap: CN¥57.5b
Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.
300765
CN¥40.77
7D
-1.0%
1Y
-23.1%
Hyphens Pharma International
Market Cap: S$114.3m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.36
7D
-1.4%
1Y
25.9%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$125.6b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$520.50
7D
-3.5%
1Y
19.9%
AbbVie
Market Cap: US$439.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$250.82
7D
2.8%
1Y
22.5%
CanSino Biologics
Market Cap: HK$10.9b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$24.70
7D
-0.2%
1Y
-50.9%
Pangaea Oncology
Market Cap: €55.7m
A precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries.
PANG
€1.55
7D
0%
1Y
-9.9%
Innovent Biologics
Market Cap: HK$165.6b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$93.80
7D
-1.1%
1Y
-3.8%
Renata
Market Cap: ৳53.7b
Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh and Portugal.
RENATA
৳471.70
7D
-0.1%
1Y
-4.6%
Teva Pharmaceutical Industries
Market Cap: US$42.8b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$36.52
7D
4.9%
1Y
108.2%
InSilico Medicine Cayman TopCo
Market Cap: HK$26.5b
Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.
3696
HK$44.56
7D
-1.9%
1Y
n/a
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.8b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€52.80
7D
0.3%
1Y
3.1%
Chugai Pharmaceutical
Market Cap: JP¥11.8t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,945.00
7D
1.3%
1Y
11.2%
Galderma Group
Market Cap: CHF 41.6b
Operates as a dermatology company worldwide.
GALD
CHF 178.55
7D
0.2%
1Y
36.3%
Aroa Biosurgery
Market Cap: AU$204.1m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.60
7D
7.1%
1Y
-4.0%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$19.02
7D
0.6%
1Y
20.7%
Merck
Market Cap: US$327.9b
Operates as a healthcare company worldwide.
MRK
US$135.55
7D
5.6%
1Y
63.8%
hVIVO
Market Cap: UK£46.0m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.067
7D
-2.9%
1Y
-34.6%
BioGaia
Market Cap: SEK 11.4b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 113.10
7D
1.3%
1Y
19.0%
Ligand Pharmaceuticals
Market Cap: US$5.8b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$288.82
7D
-3.8%
1Y
87.8%
Viyash Scientific
Market Cap: ₹116.3b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹255.60
7D
-7.8%
1Y
45.7%
Selvita
Market Cap: zł526.8m
Provides drug discovery, drug development, and contract testing services in Poland.
SLV
zł28.70
7D
2.7%
1Y
-10.3%
Strides Pharma Science
Market Cap: ₹91.2b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹967.80
7D
-3.6%
1Y
8.1%
WuXi XDC Cayman
Market Cap: HK$80.2b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$62.05
7D
0.2%
1Y
-0.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$65.7b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$69.00
7D
11.7%
1Y
180.0%
Bora Pharmaceuticals
Market Cap: NT$53.7b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$410.00
7D
-1.8%
1Y
-47.6%